Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Trendsportarten

    Trendsportarten sind u. a. gekennzeichnet durch Extremisierung und hohe Durchführungsgeschwindigkeit. Durch die entsprechende Energieeinwirkung beim Sturz entstehen typische Verletzungsverteilungen und -muster.

    Priv.-Doz. Dr. R. Meier MHBA, H. Pralle in Der Unfallchirurg (2015)

  2. No Access

    Article

    Begleitverletzungen distaler Radiusfrakturen

    Trotz der guten Resultate bzgl. anatomischer Rekonstruktion und radiologischer Ergebnisse nach distaler Radiusfraktur finden sich immer wieder schlechte funktionelle Ergebnisse. Die Ursache hierfür können karp...

    PD Dr. J. Frank, H. Pralle, M. Lehnert, I. Marzi in Der Unfallchirurg (2010)

  3. No Access

    Article

    Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial

    R F Schlenk, S Fröhling, F Hartmann, J Th Fischer, A Glasmacher, F del Valle in Leukemia (2006)

  4. No Access

    Chapter

    EDV in der Hämatologie und Onkologie

    Die Dokumentation bildet einen Grundstein der wissenschaftlichen Medizin. Ärzte waren deshalb sehr früh verpflichtet, über ihr Tun zu berichten. Mit Beginn der 70er Jahre entstanden für diese Aufgabe in den US...

    H. Pralle, M. B. Wischnewsky in Kompendium Internistische Onkologie (2006)

  5. No Access

    Chapter

    Haarzell-Leukämie

    Nur bei etwa 60% der Patienten kommen in den Blutbildern — und dann meist wenige — „hairy cells“ vor. Sie zeichnen sich durch die namensgebenden langen Ausläufer des meist weiten und unruhig gefärbten Zytoplas...

    H. Pralle, I. Schmidt-Wolf in Kompendium Internistische Onkologie (2006)

  6. No Access

    Chapter

    Haarzell-Leukämie

    Nur bei etwa 60% der Patienten kommen in den Blutbildern — und dann meist wenige — „hairy cells“ vor. Sie zeichnen sich durch die namensgebenden langen Ausläufer des meist weiten und unruhig gefärbten Zytoplas...

    H. Pralle, I. Schmidt-Wolf in Kompendium Internistische Onkologie (2006)

  7. No Access

    Article

    Gender aspects in chronic myeloid leukemia: long-term results from randomized studies

    Gender-related aspects in chronic myeloid leukemia (CML) have not been studied well. We therefore analyzed 856 patients with Ph/BCR-ABL-positive CML from the German randomized CML-studies I (interferon α (IFN) vs

    U Berger, O Maywald, M Pfirrmann, T Lahaye, A Hochhaus, A Reiter, J Hasford in Leukemia (2005)

  8. No Access

    Article

    High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia

    The objective of our study was to evaluate high-dose cytarabine in consolidation therapy in patients with newly diagnosed acute promyelocytic leukemia (APL). Patients (age 16–60 years) received induction thera...

    R F Schlenk, U Germing, F Hartmann, A Glasmacher, J T Fischer in Leukemia (2005)

  9. No Access

    Article

    Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

    The purpose of our study was (i) to evaluate the impact of all-trans retinoic acid (ATRA) given as adjunct to chemotherapy and (ii) to compare second consolidation vs maintenance therapy in elderly patients with ...

    R F Schlenk, S Fröhling, F Hartmann, J Th Fischer, A Glasmacher, F del Valle in Leukemia (2004)

  10. No Access

    Article

    Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon α

    Chronic myeloid leukemia (CML) in older patients has not been studied well. To assess the long-term outcome of older patients with Philadelphia- and/or BCR-ABL-positive CML, 199 patients aged ⩾60 years represe...

    U Berger, G Engelich, O Maywald, M Pfirrmann, A Hochhaus, A Reiter in Leukemia (2003)

  11. No Access

    Article

    Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea

    The optimum treatment conditions of interferon (IFN) α therapy in chronic myeloid leukemia (CML) are still controversial. To evaluate the role of hydroxyurea (HU) for the outcome of IFN therapy, we conducted a ra...

    R Hehlmann, U Berger, M Pfirrmann, A Hochhaus, G Metzgeroth, O Maywald in Leukemia (2003)

  12. No Access

    Article

    Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial

    The objective of the AML HD93 treatment trial was to evaluate the outcome in young adults with acute myeloid leukemia (AML) after postremission therapy was stratified according to cytogenetically defined risk....

    R F Schlenk, A Benner, F Hartmann, F del Valle, C Weber, H Pralle, JTh Fischer in Leukemia (2003)

  13. No Access

    Chapter

    Haarzell-Leukämie

    H. Pralle, W. Dempke in Kompendium Internistische Onkologie Standa… (1999)

  14. No Access

    Chapter and Conference Paper

    Stratification of Postremission Therapy in Adult Acute Myeloid Leukemia According to the Karyotype — Preliminary Results of the Multicenter Treatment Trial AML HD93

    Specific chromosome aberrations are one of the most important predictive factors for response rate and remission duration in acute myeloid leukemia (AML). In June 1993, we initiated a multicenter treatment tri...

    R. Schlenk, K. Fischer, F. del Valle, F. Hartmann, H. Pralle in Acute Leukemias VII (1998)

  15. No Access

    Article

    EDV in der Onkologie

    H. Pralle, H. Bräunlich, K. Marquardt, T. Meier, A. Michel in Der Onkologe (1997)

  16. No Access

    Chapter

    Haarzelleukämie

    Inzidenz: In der Bundesrepublik Deutschland rechnet man pro Jahr mit etwa 150 neudiagnostizierten Fällen.

    H. Pralle in Kompendium Internistische Onkologie (1997)

  17. No Access

    Article

    Immune electron-microscopy study of the trimeric glycoprotein (CD 103) of hairy cell leukemia using the Ber-ACT8 monoclonal antibody

    We describe a method which makes it possible to study the expression of the trimeric glycoprotein (TGP, CD 103) on the surface of hairy cells (HCs) by electron microscopy (e.m.). The monoclonal antibody (mAb) ...

    D. Frangoulidis, A. Schulz, H. Pralle in Annals of Hematology (1994)

  18. No Access

    Article

    Leukocytoclastic vasculitis complicating granulocyte colony-stimulating factor (G-CSF) induced neutrophil recovery in Tγ-lymphocytosis with severe neutropenia

    G. Schliesser, H. Pralle, J. Lohmeyer in Annals of Hematology (1992)

  19. Article

    Abstract

    Ch. Mache, Ch. Urban, H. Sauer, G. Brandesky, H. Meßner in Annals of Hematology (1992)

  20. No Access

    Chapter and Conference Paper

    Several Cytokines Do not Influence Activity of P210BCR-ABL Kinase in K562 Cells

    Chronic myelogenous leukemia (CML) is a disease which has, in its chronic phase, the dominant feature of a myeloproliferative disorder. It is characterized by the clonal expansion of a hematopoietic stem cell.

    A. Käbisch, T. Tamura, H. Pralle in Cytokines in Hemopoiesis, Oncology, and AIDS (1990)

previous disabled Page of 3